Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Journal of Steroid Biochemistry|November 1, 1986
Therapeutic approaches in prostatic cancerF Di Silverio, F Sciarra
European Urology|January 1, 1990
Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetateF Di Silverio, F Sciarra, G D'Eramo
Investigative Urology|January 1, 1976
Biosynthesis and metabolism of androgenic hormones in cancer of the prostateF Di Silverio, V Gagliardi, G Sorcini, et al.
European Urology|January 1, 1990
Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian studyF Di Silverio, M Serio, G D'Eramo, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 20, 1990
Antiandrogens: clinical applicationsF Sciarra, V Toscano, G Concolino, et al.
European Urology|January 1, 1990
Incidental prostatic carcinoma: four-year follow-up after treatment with cyproterone acetateF Di Silverio, F Sciarra, G D'Eramo, et al.
British Journal of Urology|April 1, 1977
Hormonal pattern in prostatic carcinoma following orchidectomy: 5-year follow-upU Bracci, F Di Silverio, F Sciarra, et al.
Journal of Steroid Biochemistry|January 1, 1988
Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasiaE Petrangeli, F Sciarra, F Di Silverio, et al.
Urological Research|January 1, 1995
Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissueF Sciarra, S Monti, M V Adamo, et al.
Journal of Andrology|September 11, 1998
Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH)S Monti, F Di Silverio, V Toscano, et al.
Pageof 15